TABLE 3.

Application site reactions

Reaction	No. (%) of patients
	Placebo (n = 32a)	1% cidofovir (n = 20)	3% cidofovir (n = 21)	5% cidofovir (n = 23)	Combined cidofovir (n = 64)
Any application site reaction	1 (3)	1 (5)	4 (19)	5 (22)	10 (16)
Dry skin	0 (0)	0 (0)	1 (5)	0 (0)	1 (2)
Pain	0 (0)	0 (0)	1 (5)	0 (0)	1 (2)
Paresthesia	0 (0)	0 (0)	0 (0)	1 (4)	1 (2)
Pruritus	0 (0)	0 (0)	0 (0)	1 (4)	1 (2)
Rash	1 (3)	0 (0)	1 (5)	2 (9)	3 (5)
Skin discoloration	0 (0)	0 (0)	1 (5)	2 (9)	3 (5)
Skin disorder	0 (0)	0 (0)	0 (0)	1 (4)	1 (2)
Skin hypertrophy	1 (3)	1 (5)	0 (0)	0 (0)	0 (0)
Ulcer	0 (0)	0 (0)	1 (5)	3 (13)	4 (6)

^aTotal number of patients in the group.